WIN-PARTNERS Reports Third Quarter Earnings Results for FY2023

Earnings Overview

On February 14 2023, WIN-PARTNERS ($TSE:3183) announced their fiscal third quarter results which had ended on December 31 2022. Total revenue for the period was recorded as JPY 810.0 million, representing a 22.3% increase from the same quarter of the prior year. Net income was reported to be JPY 17735.3 million, a slight 0.1% increase from the previous year.

Market Price

3 % . E a r n i n g s p e r s h a r e a l s o i n c r e a s e d b y 1 2 . T h e c o m p a n y ‘ s C E O c o m m e n t e d t h a t ” w e a r e p l e a s e d t o h a v e d e l i v e r e d a s o l i d p e r f o r m a n c e i n s u c h a c h a l l e n g i n g e n v i r o n m e n t a n d w e l o o k f o r w a r d t o c o n t i n u e d g r o w t h i n t h e c o m i n g q u a r t e r s. Live Quote…

About the Company

Income Snapshot

Below shows the total revenue, net income and net margin for Win-partners. More…

Cash Flow Snapshot

Below shows the cash from operations, investing and financing for Win-partners. More…

Balance Sheet Snapshot

Below shows the total assets, liabilities and book value per share for Win-partners. More…

Key Ratios Snapshot

Some of the financial key ratios for Win-partners are shown below. More…

Analysis

After conducting an analysis of WIN-PARTNERS‘s financials, our Star Chart revealed that WIN-PARTNERS is strong in asset, dividend, and medium in profitability, but weak in growth. WIN-PARTNERS can be classified as a ‘cow’, a type of company that has a track record of paying out consistent and sustainable dividends. As such, WIN-PARTNERS is likely to attract investors looking for steady, long-term income from dividends. With a high health score of 10/10 with regard to its cashflows and debt, WIN-PARTNERS is well-positioned to both pay off debt and fund future operations. This makes it an attractive option for investors who are looking for companies that can offer stable returns over the long term. More…

Peers

They have a wide range of products and services that are tailored to the needs of their clients, from medical equipment to solutions for healthcare facilities. They are well-known for their quality and customer service. Their competitors include Salus, Shenzhen Glory Medical Co Ltd, and PT Itama Ranoraya Tbk which are all well-established and respected providers in the medical and healthcare industries.

– Salus ($LTS:0HMV)

Salus is a medical device company that specializes in the development of innovative medical technology that improves patient health outcomes. As of 2023, the company has a market capitalization of 146.12 million dollars. Salus is known for its strong financial performance, as evidenced by its 13.73% return on equity. This ROE shows that the company is able to generate a high rate of return from each dollar invested in the company. As such, Salus is a great investment for many investors looking for a strong return on their money.

– Shenzhen Glory Medical Co Ltd ($SZSE:002551)

Shenzhen Glory Medical Co Ltd is a medical device and pharmaceutical company based in Shenzhen, China. The company specializes in producing medical equipment, drugs, and medical instruments. As of 2023, Shenzhen Glory Medical Co Ltd has a market cap of 3.94B and a Return on Equity of -1.55%. This market cap reflects the company’s current market value, and the ROE indicates that the company is not performing as well as expected. The negative return on equity might indicate that the company is not utilizing its resources effectively. Nonetheless, the company continues to be a leader in the medical device and pharmaceutical industry.

– PT Itama Ranoraya Tbk ($IDX:IRRA)

Itama Ranoraya Tbk is a Jakarta-based company that specializes in providing integrated solutions for industrial and infrastructure projects. The company has a market capitalization of 1.59 trillion as of 2023, which reflects its strong financial position. Its return on equity of 11.8% indicates that it is efficiently utilizing its resources to generate returns for its shareholders. Additionally, its diversified portfolio of businesses and its commitment to innovation are key factors driving the company’s success.

Summary

By investing in WIN-PARTNERS, investors have realized a 22.3% increase in revenues from the same quarter of the previous year. Net income for the quarter remained steady at JPY 17735.3 million, a marginal 0.1% increase year over year. This growth trend indicates a positive outlook for the company to continue generating profits in the future. Analysts suggest that long term investors in WIN-PARTNERS may see good returns over time.